Results 91 to 100 of about 75,748 (340)
Abstract Aims Natriuretic peptide‐based pre‐heart failure screening has been proposed in recent guidelines. However, an effective strategy to identify screening targets from the general population, more than half of which are at risk for heart failure or pre‐heart failure, has not been well established.
Yuichiro Mori +5 more
wiley +1 more source
The predictive value of preoperative B-type natriuretic peptide in children undergoing cardiac surgery [PDF]
Introduction: B-type natriuretic peptide (BNP) is a biomarker of myocardial stress. In children, the value of preoperative BNP on postoperative outcome is unclear.
Boulos, T.
core
N-terminal pro-B-type natriuretic peptide and risk of future cognitive impairment in the REGARDS cohort [PDF]
Background: Improved understanding of the etiology of cognitive impairment is needed to develop effective preventive interventions. Higher amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac dysfunction associated with ...
Callas, Peter W. +7 more
core +1 more source
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot +8 more
wiley +1 more source
Korelasi Kadar NT- proBNP dengan Fungsi Fraksi Ejeksi Ventrikel Kiri pada Gagal Jantung Anak
Latar belakang. NT proBNP sudah digunakan secara luas sebagai penanda terpercaya untuk mengetahui disfungsi ventrikel dan gagal jantung pada dewasa, penelitian pada bidang pediatrik masih terbatas. Tujuan.
Khairunnisa Syamsi +2 more
doaj +1 more source
Biomarkers in acute coronary syndromes and their role in diabetic patients [PDF]
Diabetic patients with acute coronary syndromes are at high risk for cardiovascular complications but risk stratification in these patients remains challenging.
Christopher Heeschen +5 more
core +1 more source
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki +11 more
wiley +1 more source
Background. The NT-ProBNP/BNP test has been validated as a marker for determining the etiology of acute dyspnea. In the setting of end-stage renal disease on hemodialysis (ESRD on HD), the utility of the NT-ProBNP/BNP test has not been validated.
Shaffer R. S. Mok +3 more
doaj +1 more source
Troponin and NT-proBNP in the prediction of impaired myocardial deformation after STEMI [PDF]
Raluca Tomoaia +10 more
openalex +1 more source
Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function [PDF]
Clinical biomarkers of cardiac function could also be monitored postmortem. Among the natriuretic peptides, the aminoterminal portion of pro-brain natriuretic peptide (NT-proBNP) appears to be a more reliable postmortem tool than the BNP, owing to its ...
Augsburger, Marc +6 more
core

